The expression of circulating hsa-miR-126-3p in dengue-infected Thai pediatric patients

References

• Wang WH, Urbina AN, Chang MR, et al. Dengue hemorrhagic fever - a systemic literature review of current perspectives on pathogenesis, prevention and control. J Microbiol Immunol Infect. 2020;53(6):963–978.
   PubMedGoogle Scholar
• Guzman MG, Gubler DJ, Izquierdo A, et al. Dengue infection. Nat Rev Dis Primers. 2016;2:16055.
   PubMed Web of Science ®Google Scholar
• Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012;366(15):1423–1432.
   PubMed Web of Science ®Google Scholar
• World Health Organization: Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue hemorrhagic fever: revised and expanded edition. India: World Health Organization (WHO) Press; 2011.
   Google Scholar
• Xavier-Carvalho C, Cardoso CC, de Souza Kehdy F, et al. Host genetics and dengue fever. Infect Genet Evol. 2017;56:99–110.
   PubMed Web of Science ®Google Scholar
• Limkittikul K, Brett J, L’Azou M. Epidemiological trends of dengue disease in Thailand (2000-2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):e3241.
   PubMed Web of Science ®Google Scholar
• Sabchareon A, Sirivichayakul C, Limkittikul K, et al. Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009. PLoS Negl Trop Dis. 2012;6(7):e1732.
   PubMed Web of Science ®Google Scholar
• Sirivichayakul C, Limkittikul K, Chanthavanich P, et al. Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations. PLoS Negl Trop Dis. 2012;6(2):e1520.
   PubMed Web of Science ®Google Scholar
• Hammond SN, Balmaseda A, Perez L, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005;73(6):1063–1070.
   PubMed Web of Science ®Google Scholar
• Namvongsa V, Sirivichayakul C, Songsithichok S, et al. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health. 2013;44(5):772–779.
   PubMedGoogle Scholar
• Verhagen LM, de Groot R. Dengue in children. J Infect. 2014;69(1):S77–86.
   PubMedGoogle Scholar
• Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 2009;102(6):1042–1049.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25–30.
   PubMed Web of Science ®Google Scholar
• Wong RR, Abd-Aziz N, Affendi S, et al. Role of microRNAs in antiviral responses to dengue infection. J Biomed Sci. 2020;27(1):4.
   PubMed Web of Science ®Google Scholar
• Mishra R, Lata S, Ali A, et al. Dengue haemorrhagic fever: a job done via exosomes? Emerg Microbes Infect. 2019;8(1):1626–1635.
   PubMed Web of Science ®Google Scholar
• Cerutti C, Edwards LJ, de Vries HE, et al. MiR-126 and miR-126* regulate shear- resistant firm leukocyte adhesion to human brain endothelium. Sci Rep. 2017;7(1):45284.
   PubMedGoogle Scholar
• Aloia AL, Abraham AM, Bonder CS, et al. Dengue virus-induced inflammation of theEndothelium and the potential roles of sphingosine kinase-1 and MicroRNAs. Mediators Inflamm. 2015;2015:509306.
   PubMed Web of Science ®Google Scholar
• Sasahira T, Kurihara M, Bhawal UK, et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer. 2012;107(4):700–706.
   PubMed Web of Science ®Google Scholar
• Qu M, Pan J, X-j S, et al. MicroRNA-126 is a prospective target for vascular disease. Neuroimmunol Neuroinflammation. 2018;5(4):10.
   Google Scholar
• Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A. 2008;105(5):1516–1521.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang L, Huang H, et al. Serum miR-126-3p level is down-regulated in sepsis patients. Int J Clin Exp Pathol. 2018;11(5):2605–2612.
   PubMed Web of Science ®Google Scholar
• Elfiky AM, Ahmed Mahmoud A, Zeidan HM, et al. Association between circulating microRNA-126 expression level and tumour necrosis factor alpha in healthy smokers. Biomarkers. 2019;24(5):469–477.
   PubMed Web of Science ®Google Scholar
• Zhang T, Li L, Shang Q, et al. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun. 2015;463(1–2):60–63.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107(5):677–684.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Jiang X, Gu D, et al. Dysregulated serum miRNA profile and promising biomarkers in dengue-infected patients. Int J Med Sci. 2016;13(3):195–205.
   PubMed Web of Science ®Google Scholar
• Tambyah PA, Ching CS, Sepramaniam S, et al. microRNA expression in blood of dengue patients. Ann Clin Biochem. 2016;53(Pt 4):466–476.
   PubMed Web of Science ®Google Scholar
• Saini J, Bandyopadhyay B, Pandey AD, et al. High-Throughput RNA sequencing analysis of plasma samples reveals circulating microRNA signatures with biomarker potential in dengue disease progression. mSystems. 2020;5(5). DOI:10.1128/mSystems.00724-20.
   PubMed Web of Science ®Google Scholar
• Chamorro-Jorganes A, Araldi E, Suarez Y. MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res. 2013;75:15–27.
   PubMed Web of Science ®Google Scholar
• Chen RF, Yang KD, Lee IK, et al. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever. J Infect. 2014;69(4):366–374.
   PubMed Web of Science ®Google Scholar
• Ghorbani S, Mahdavi R, Alipoor B, et al. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Arch Physiol Biochem. 2018;124(4):300–305.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Kawada J, Kamiya Y, et al. Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection. J Perinatol. 2016;36(12):1101–1105.
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127(1):118–126.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Dalrymple NA, Mackow ER. Roles for endothelial cells in dengue virus infection. Adv Virol. 2012;2012:840654.
   PubMedGoogle Scholar
• Duan Y, Zou J, Mao J, et al. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to tripterygium wilfordii hook F in combination with Acitretin. Biomed Pharmacother. 2019;115:108761.
   PubMed Web of Science ®Google Scholar
• Moran J, Ramirez-Martinez G, Jimenez-Alvarez L, et al. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection. Exp Mol Pathol. 2015;99(2):253–261.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lv C, Li L, et al. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int. 2013;2013:761617.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu Y, Jin F, et al. Differential expression of circulating microRNAs in blood and haematoma samples from patients with intracerebral haemorrhage. J Int Med Res. 2016;44(3):419–432.
   PubMed Web of Science ®Google Scholar
• Vervaeke P, Vermeire K, Liekens S. Endothelial dysfunction in dengue virus pathology. Rev Med Virol. 2015;25(1):50–67.
   PubMed Web of Science ®Google Scholar
• Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339(6221):237–238.
   PubMed Web of Science ®Google Scholar